I reported previously (see here) on Israel’s Alpha Tau and its Alpha DaRT radiation therapy for cancer patients. It has just obtained UK certification following an audit by the British Standards Institution – the UK’s independent compliance body. https://www.prnewswire.com/news-releases/breakthrough-cancer-therapy-developer-alpha-tau-awarded-iso-13485-certificate-for-quality-management-of-medical-devices-300830619.html

Good results of the first multi-center human trials of the Alpha Dart radiation therapy (see here) developed by Israel’s Alpha Tau. Over 78% of the skin cancer tumors were completely cured. Most of the patients had previously received other treatments … Continue reading →

Tel Aviv University scientists have discovered a new method for detecting the aggregation of the protein alpha-synuclein, before Parkinson’s symptoms appear. Doctors can then monitor how treatments affect this aggregation. https://www.jpost.com/Israel-News/TAU-unveils-new-method-for-detecting-delaying-Parkinsons-591602 https://link.springer.com/article/10.1007/s00401-019-02023-x

I reported previously (9th Sep) on Israel’s Alpha Tau’s radiation emitters starting trials in the USA.  Trials have also been launched at two centers in Rome, Italy. But I should have mentioned that 70% of patients in earlier Israeli and … Continue reading →